Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group von Kuter, B J, Ngai, A, Patterson, C M, Staehle, B O, Cho, I, Matthews, H, Provost, P J, White, C J

Volltext

Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax ®) in healthy adolescents and adults von Kuter, Barbara J., Ngai, Angela, Patterson, Carolyn M., Staehle, Brenda O., Cho, Iksung, Matthews, Holly, Provost, Philip J., Jo White, C., the Oka/Merck Varicella Vaccine Study Group

Volltext

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX™ in healthy children von Lau, Yu-Lung, Vessey, S.J.Rupert, Chan, Ivan S.F, Lee, Tsz-Leung, Huang, Li-Min, Lee, Chin-Yun, Lin, Tzou-Yien, Lee, Bee Wah, Kwan, Kow, Kasim, Siti M, Chan, Christina Y, Kaplan, Karen M, Distefano, Daniel J, Harmon, Anna L, Golie, Amy, Hartzel, Jonathan, Xu, Jin, Li, Shu, Matthews, Holly, Sadoff, Jerald C, Shaw, Alan

Volltext

Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/Merck varicella vaccine. NIAID Varicella Vaccine Collaborative Study Group von Lydick, E, Kuter, B J, Zajac, B A, Guess, H A

Volltext

Immunogenicity of oka/merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age von SILBER, Jeffrey L, CHAN, Ivan S. F, WANG, William W, MATTHEWS, Holly, KUTER, Barbara J

Volltext

Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine von BERNSTEIN, H. H, ROTHSTEIN, E. P, WATSON, B. M, REISINGER, K. S, BLATTER, M. M, WELLMAN, C. O, CHARTRAND, S. A, CHO, I, NGAI, A, WHITE, C. J

Volltext

Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies von Kuter, Barbara J., Weibel, Robert E., Guess, Harry A., Matthews, Holly, Morton, David H., Neff, Beverly J., Provost, Philip J., Watson, Barbara A., Starr, Stuart E., Plotkin, Stanley A.

Volltext

Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children von NGAI, A. L, STAEHLE, B. O, KUTER, B. J, CYANOVICH, N. M, IKSUNG CHO, MATTHEWS, H, KELLER, P, ARVIN, A. M, WATSON, B, WHITE, C. J

Volltext

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults von Pellissier, James M, Brisson, Marc, Levin, Myron J

Volltext

Sustainability of humoral responses to varicella vaccine in pediatric transplant recipients following a pretransplantation immunization strategy von Barton, Michelle, Wasfy, Samia, Melbourne, Toni, Hébert, Diane, Moore, Dorothy, Robinson, Joan, Marchese, Rocio D., Allen, Upton D.

Volltext

Zoster vaccine live (Oka/Merck) von Robinson, Dean M, Perry, Caroline M

Volltext

The Effect of Decreasing Amounts of Live Virus, while Antigen Content Remains Constant, on Immunogenicity of Oka/Merck Varicella Vaccine von Watson, Barbara, Piercy, Sharon, Soppas, Despina, Browngoehl, Kevin, Warner, Mark, Isganitis, Kathy, White, C. J., Kuter, Barbara, Chua, Janet, Starr, Stuart

Volltext

Varicella-Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine von Levin, M. J., Oxman, M. N., J. H. Zhang, Johnson, G. R., Stanley, H., Hayward, A. R., Caulfield, M. J., Irwin, M. R., Smith, J. G., Clair, J., Chan, I. S. F., Williams, H., Harbecke, R., Marchese, R., Straus, S. E., Gershon, A., Weinberg, A.

Volltext

Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children von DENNEHY, P. H, REISINGER, K. S, BLATTER, M. M, VELOUDIS, B. A

Volltext

Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/Merck varicella vaccine von Lydick, Eva, Kuter, Barbara J., Zajac, Barbara A., Guess, Harry A.

Volltext

Immunogenicity of Varicella Vaccine and Immunologic Predictors of Response in a Cohort of Elderly Nursing Home Residents von Lelic, Alina, Verschoor, Chris P., Lau, Vivian W. C., Parsons, Robin, Evelegh, Carole, Bowdish, Dawn M., Bramson, Jonathan L., Loeb, Mark B.

Volltext

Varicella-zoster vaccine in the USA: success for control of disease severity, but what next? von Watson, Barbara

Volltext

Herpes zoster vaccine live: A 10 year review of post-marketing safety experience von Willis, English D., Woodward, Meredith, Brown, Elizabeth, Popmihajlov, Zoran, Saddier, Patricia, Annunziato, Paula W., Halsey, Neal A., Gershon, Anne A.

Volltext

Zoster Vaccine Live (Oka/Merck): A Viewpoint by Anthony L. Cunningham von Cunningham, Anthony L

Volltext

Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain? von Harbecke, Ruth, Jensen, Nancy J., Depledge, Daniel P., Johnson, Gary R., Ashbaugh, Mark E., Schmid, D. Scott, Breuer, Judith, Levin, Myron J., Oxman, Michael N.

Volltext